Skip to main content
Conference Coverage

Should Pemetrexed Be Continued in Patients Who Receive the KEYNOTE-189 Regimen?

Featuring Edward Garon, MD, MS

 

At the Great Debates and Updates in Lung Cancer Meeting in New York, New York, Edward Garon, MD, MS, Jonsson Comprehensive Cancer Center, Santa Monica, California, argued that pemetrexed maintenance therapy should eventually be stopped. 


Source: 

Garon E. Debate: Should Pemetrexed Be Continued in KEYNOTE-189? Presented at Great Debates & Updates in Lung Cancer; April 27-28, 2024; New York, NY.

© 2024 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Oncology Learning Network or HMP Global, their employees, and affiliates.